BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29982409)

  • 1. Platelet Survival in Hematology Patients Assessed by the Corrected Count Increment and Other Formulas.
    Jaime-Pérez JC; Vázquez-Hernández KE; Jiménez-Castillo RA; Fernández LT; Salazar-Riojas R; Gómez-Almaguer D
    Am J Clin Pathol; 2018 Jul; 150(3):267-272. PubMed ID: 29982409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttransfusion platelet count increments after ABO-compatible versus ABO-incompatible platelet transfusions in noncancer patients: an observational study.
    Pavenski K; Warkentin TE; Shen H; Liu Y; Heddle NM
    Transfusion; 2010 Jul; 50(7):1552-60. PubMed ID: 20210928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.
    Eriksson L; Kristensen J; Olsson K; Bring J; Högman CF
    Vox Sang; 1996; 70(2):69-75. PubMed ID: 8801766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing 20-hour increments after platelet transfusion.
    Bishop JF; Matthews JP; McGrath K; Yuen K; Wolf MM; Szer J
    Transfusion; 1991 Jun; 31(5):392-6. PubMed ID: 2048176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrected count increment and percent platelet recovery as measures of posttransfusion platelet response: problems and a solution.
    Davis KB; Slichter SJ; Corash L
    Transfusion; 1999 Jun; 39(6):586-92. PubMed ID: 10378838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of cross-match compatible platelets in multi transfused haemato-oncology patients refractory to platelet transfusion.
    Chavan A; Sharma RR; Saikia B; Malhotra P; Prakash S; Hans R; Marwaha N
    Transfus Apher Sci; 2019 Dec; 58(6):102657. PubMed ID: 31706911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of efficacy of low and high dose prophylactic platelet transfusion therapy in thrombocytopenic haemato-oncology patients.
    Dhiman Y; Hans R; Sharma RR; Malhotra P; Marwaha N
    Transfus Apher Sci; 2020 Feb; 59(1):102610. PubMed ID: 31345687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Human Leucocyte Antigen Mediated Platelet Transfusion Refractoriness and Platelet Crossmatching Assay in Patients with Hematologic Disorders.
    Neanaey WA; Deghady AA; Nafea DA; Fahmy NM; Gouda AM
    Oman Med J; 2022 Jul; 37(4):e402. PubMed ID: 35915764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective observational study to compare transfusion outcomes in ABO identical versus ABO non-identical single donor platelet concentrates: An experience from a tertiary healthcare center in India.
    Pandey P; Kumari S; Mandal S; Setya D; Kumar P
    Transfus Clin Biol; 2022 Aug; 29(3):213-218. PubMed ID: 35667592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of apheresis platelet manipulation on corrected count increment.
    Karafin M; Fuller AK; Savage WJ; King KE; Ness PM; Tobian AA
    Transfusion; 2012 Jun; 52(6):1221-7. PubMed ID: 22233358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical factors influencing posttransfusion platelet increment in patients undergoing hematopoietic progenitor cell transplantation--a prospective analysis.
    Ishida A; Handa M; Wakui M; Okamoto S; Kamakura M; Ikeda Y
    Transfusion; 1998 Sep; 38(9):839-47. PubMed ID: 9738624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Improvement of bleeding tendency and normalized platelet count increment following splenectomy in a patient with refractory anemia].
    Kawai Y; Fukushima T; Ookura K; Yoshio N; Yamauchi T; Nakayama T; Tohyama K; Wano Y; Tsutani H; Ueda T; Nakamura T
    Rinsho Ketsueki; 1997 Jun; 38(6):532-8. PubMed ID: 9248330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of different types of platelet concentrates in thrombocytopenic patients.
    Singh RP; Marwaha N; Malhotra P; Dash S
    Indian J Hematol Blood Transfus; 2008 Mar; 24(1):16-22. PubMed ID: 23100935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravascular and total body platelet equilibrium in healthy volunteers and in thrombocytopenic patients transfused with single donor platelets.
    Brubaker DB; Marcus C; Holmes E
    Am J Hematol; 1998 Jul; 58(3):165-76. PubMed ID: 9662266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Influencing Corrected Count Increment After Platelet Transfusion in Thrombocytopenic Patients.
    Prasad Sahu D; Wasnik M; Kannauje PK
    Cureus; 2023 Sep; 15(9):e46161. PubMed ID: 37908942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABO and platelet transfusion revisited.
    Heal JM; Rowe JM; Blumberg N
    Ann Hematol; 1993 Jun; 66(6):309-14. PubMed ID: 8318561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretransfusion incubation of apheresis platelets at 37 degrees C improves posttransfusion recovery.
    Shanwell A; Wikman A; Ringdén O
    Transfusion; 1992 Oct; 32(8):715-8. PubMed ID: 1412678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Storage-induced change in platelet transfusion response evaluated by serial transfusions from one donor to one patient.
    Tynngård N; Boknäs N; Trinks M; Dreimane A; Berlin G
    Transfusion; 2019 Feb; 59(2):723-728. PubMed ID: 30548486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet corrected count increments by apheresis platform.
    Tobian AA; King KE; Borge PD; Fuller AK; Uglik K; Ness PM
    Transfusion; 2016 Oct; 56(10):2584-2586. PubMed ID: 27572682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.